TT Electronics FY2025: Operational Turnaround, Strong Cash, and a Sharper Strategy
TT Electronics has posted a year of two halves. 2025 was billed as a transition year, and that is exactly what the numbers show: operational fixes taking hold, cash flowing strongly, and a clearer strategic direction for 2026. Revenue fell on paper, but profitability and cash discipline improved, especially in the back half.
Headline numbers investors should know
| Metric | FY2025 | Change |
|---|---|---|
| Revenue (statutory) | £481.4 million | (7.6)% |
| Revenue (organic) | £481.4 million | (2.7)% |
| Adjusted operating profit (organic) | £37.2 million | +2.2% |
| Adjusted operating margin (organic) | 7.7% | +30 bps |
| Statutory operating loss | £(28.2) million | worse by £4.7 million |
| Free cash flow | £29.9 million | +7.9% |
| Cash conversion | 150% | +33 pts |
| Net debt (excl. leases) | £50.3 million | improved from £80.1 million |
| Leverage | 1.1x | from 1.8x |
| Book to bill ratio | 109% | from 102% |
| Adjusted EPS | 6.9p | (37.3)% |
| Dividend | None declared for 2025 | not applicable |
Quick jargon buster: “Adjusted” excludes one-off items to show underlying trading. “Book to bill” compares orders in the period with revenue; over 100% signals future growth. “Leverage” is net debt divided by EBITDA, a standard measure of balance sheet risk.
Where the growth and pressure showed up by market
- Aerospace & Defence: £152.8 million, up from £136.4 million. Europe led the charge with high-margin programmes.
- Healthcare: £107.8 million, down from £112.6 million.
- Automation & Electrification: £140.1 million, down from £161.1 million as industrial demand softened.
- Distribution: £80.7 million, down from £84.7 million as component buying normalised.
Regional performance: Europe shines, North America repairs, Asia resets
Europe delivered margin leadership
Europe posted an adjusted operating margin of 15.3% with profit up 16.9%, helped by repricing, better execution, and strong A&D programmes. The regional book to bill hit 135%, indicating solid visibility into 2026.
North America’s operational triage worked
Adjusted operating profit improved to £1.2 million from a £2.7 million loss in 2024. The turnaround was driven by actions at the Cleveland plant, which broke even on an adjusted basis in Q4, and the closure of the structurally loss-making Plano site. Plano still generated £13.0 million of revenue and c.£3.5 million of last-time-buy profit in H2, translating into a £1.2 million contribution for the year.
The sting in the tail is statutory: North America took the brunt of £41.4 million of impairments, including £37.2 million of goodwill. Painful, but non-cash.
Asia took a breather but exits stronger
Asia saw adjusted operating profit fall 24.2% to £21.6 million on lower EMS demand and the disruption of a customer transfer from Suzhou to Kuantan. The move is now complete, with Kuantan ready to ramp volumes in 2026.
Cash is king: inventory squeeze drives stellar conversion
Cash conversion hit 150% thanks to £14.8 million of underlying inventory reductions and tighter working capital control. Free cash flow rose to £29.9 million. Net debt excluding leases dropped to £50.3 million, pulling leverage down to 1.1x. That is well inside banking covenants and gives management room to manoeuvre.
The Revolving Credit Facility has been extended to June 2028 and resized to £105.0 million, which fits the slimmer footprint and lower leverage profile.
Why adjusted EPS fell even as trading improved
Adjusted EPS fell to 6.9p despite higher adjusted profit. The culprit is tax: the adjusted effective tax rate jumped to 57.1% because TT cannot currently recognise a deferred tax asset for US losses. Management notes that if recognition had been possible, adjusted EPS would have been 12.0p with a 25.4% tax rate. In short, this is an accounting headwind, not a cash one, but it still matters for reported earnings.
One-offs and clean-up costs: taking the medicine
Statutory results were dragged by £65.4 million of adjusting items, mostly non-cash. These included £41.4 million of impairments in North America, £15.2 million of restructuring (Plano closure and Cleveland support), £2.6 million of acquisition-related amortisation and £4.3 million of costs linked to the aborted Cicor approach and other M&A activity. The clear intent is to reset the base, fix underperforming assets, and focus capital where returns are strongest.
2026 game plan: divisional realignment and cost-out
- New structure: moving to Power, EMS and Components divisions to align with customers and capabilities.
- Cost reduction: c.£3 million net benefit expected in 2026, with medium-term annualised savings at roughly double that.
- Sales transformation: investment in people, pricing discipline and CRM has already lifted H2 order intake; the priority is EMS in North America and Asia.
- Components strategic review: options include a potential disposal, guided by value and market conditions.
Guidance is cautious but steady: the Board expects 2026 revenue and adjusted operating profit to be in line with company compiled consensus of £477.1 million to £487.1 million for revenue and £31.9 million to £37.6 million for adjusted operating profit.
My take: what’s good, what’s not, and why it matters
Positives
- Cash discipline is excellent. 150% cash conversion and leverage at 1.1x give strategic flexibility.
- Europe is delivering high-quality margin in attractive A&D markets, and order intake is strong.
- North American execution is improving, with Cleveland stabilising and the Plano drag removed.
- Book to bill at 109% signals rebuilding momentum after a reset year.
- Return on invested capital improved to 13.3% from 10.0%.
Watch-outs
- Statutory losses and large non-cash impairments highlight how much heavy lifting is still required in North America.
- EMS demand remains mixed, particularly in North America and Asia, which could cap near-term growth.
- No dividend for 2025. Management says it will keep this under review, but cash will first support operational progress and balance sheet strength.
- Adjusted tax rate remains elevated until US profitability is clearer; EPS is sensitive to this accounting call.
What to watch in 2026
- Cleveland’s path to sustainable profitability and order growth to lift utilisation.
- Kuantan’s volume ramp following the Suzhou transfer and broader Asia-for-Asia wins.
- Delivery of c.£3 million net cost saves and evidence of improved EMS margins.
- Outcome of the Components review, including any disposal and proceeds redeployment.
- Order intake staying above revenue, especially in A&D, to keep book to bill above 100%.
Overall, TT Electronics looks more controlled and better capitalised after a tough reset. If the operational improvements bed in and A&D strength persists, 2026 should show steadier margins and solid cash again. The equity debate now shifts from survival and clean-up to delivery and optionality.
